Janus Henderson Global Life Sciences Fund
JFNIX
Updated: 22/09/2026, 21:42:51
The fund primarily aims to achieve its investment objectives by allocating a minimum of 80% of its net capital (which may include funds borrowed for investment purposes) to securities of companies that its portfolio manager identifies as having a strong orientation towards life sciences. Additionally, as a core principle, the fund generally pledges to invest at least 25% of its overall assets in businesses specifically categorized within the "life sciences" sector.
No summaries found.
- Share price
- $88.80
- Market cap
- $5.88B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 06/07/2009
- Beta
- 0.66
- Last dividend
- $0.00
- Day range
- $88.80 – $88.80
- 52-week range
- $68.93 – $94.43
- 1-day performance
- 0.43%
- 1-year performance
- 28.83%
- Current drawdown (1Y)
- -5.96%
- CIK
- 0000277751
- CUSIP
- 471023465
- ISIN
- US4710234653
- Created
- 07/12/2025, 04:50:56
- Last update
- 22/09/2026, 21:42:51
Track Janus Henderson Global Life Sciences Fund with an AI analyst
See which prediction-market events move JFNIX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.